申请人:HOKURIKU SEIYAKU CO., LTD.
公开号:EP1149832A1
公开(公告)日:2001-10-31
A novel benzamide derivative represented by the following general formula:
wherein R represents an alkyl group having 3 to 6 carbon atoms or a salt thereof, and a medicament comprising said derivative as an active ingredient. The medicament has excellent enhancing action on gastrointestinal tract motility, and is orally available with reduced side effects. Therefore, the medicament is extremely useful as an agent for therapeutic treatment of digestive diseases, an agent for improving function of gastrointestinal tract motility and the like.
一种由以下通式表示的新型苯甲酰胺衍生物:
其中 R 代表具有 3 至 6 个碳原子的烷基或其盐,以及以上述衍生物为有效成分的药物。该药物对胃肠道蠕动有极好的促进作用,而且口服副作用小。因此,该药物作为治疗消化系统疾病的药物、改善胃肠道蠕动功能的药物等非常有用。